This study of ventilated patients investigated pneumonia risk factors and outcome predictors in 476 episodes of pneumonia (48% community-acquired pneumonia, 24% hospital-acquired pneumonia, 28% ventilator-associated pneumonia) using a prospective survey in 14 intensive care units within Australia and New Zealand. For community acquired pneumonia, mortality increased with immunosuppression (OR 5.32, P<0.01), clinical signs of consolidation (OR 2.43, P=0.03) and Sepsis-Related Organ Failure Assessment (SOFA) scores (OR 1.19, CI 95% 1.08-1.30, P<0.001) but improved if appropriate antibiotic changes were made within three days of intensive care unit admission (OR 0.42, immunosuppression (OR 6.98, P=0.02) were the principal mortality predictors. Alcoholism (OR 7.80, P<0.001), high SOFA scores (OR 1.44, P=0.001) and the isolation of "high risk" organisms including Pseudomonas aeruginosa, Acinetobacter spp, Stenotrophomonas spp and methicillin resistant Staphylococcus aureus (OR 4.79,.03, P=0.01), were associated with increased mortality in ventilator-associated pneumonia. The use of non-invasive ventilation was independently protective against mortality for patients with community-acquired and hospital-acquired pneumonia (OR 0.35, P=0.002). Mortality was similar for patients requiring both invasive and non-invasive ventilation and non-invasive ventilation alone (21% compared with 20% respectively, P=0.56).
Pneumonia managed in the intensive acre unit (ICU) is a common condition with substantial mortality 1 . Previous studies have differed in their diagnostic protocols or were from single centres 2, 3 . Studies of nosocomial pneumonia in the ICU have concentrated on ventilator associated pneumonia (VAP) or combined patients with pneumonia acquired within hospital prior to ICU admission (HAP) with VAP patients. With little information available within the Australian and New Zealand region, this study aimed to examine pneumonia risk factors and mortality predictors in mechanically ventilated patients.
METHODS
Fourteen ICUs from the membership of the Clinical Trials Group of the Australian and New Zealand Intensive Care Society (CTG-ANZICS) prospectively aimed to enrol 100 consecutive admissions requiring invasive or non-invasive ventilation and an admission diagnosis of pneumonia, or patients ventilated for more than 48 hours, irrespective of their admission diagnosis. A detailed description of the methodology, definitions and data collected are presented in an allied report 4 . In summary, patient demographics, primary diagnoses, pre-existing illness using the classification of McCabe 5 , Simplified Acute Physiologic Score (SAPS) II score 6 and outcome were recorded for all patients. The attending consultant diagnosed pneumonia using published definitions [7] [8] [9] , subjectively graded their diagnostic confidence (high >50% likelihood, medium 20-50% likelihood, low <20% likelihood) and illness severity. Data for pneumonia patients included clinical signs and Sepsisrelated Organ Failure Assessment (SOFA) scores 10 . Clinical signs of consolidation were bronchial breathing or crackles on physical examination. Antibiotics were inappropriate when the causative organism on routine laboratory testing was resistant to all prescribed antibiotics. The comparison group for pneumonia patients was non-pneumonia (NP) patients needing ventilation for more than 48 hours.
Sample Size and Statistical Methods
Analysis methods and sample estimation for the survey were determined for the allied investigation of the management of pneumonia 4 . Logistic regression was used to assess pneumonia risk factors and mortality predictors as the assumptions for proportional hazards were not met. Goodness-of-fit assessment used the method of Homser and Lemeshow 11 .
RESULTS
Eight of the 14 intensive care units were in tertiary referral teaching hospitals and contributed 64% of enrolments. Table 1 details the demographic data. Of 476 episodes of pneumonia, 230 were communityacquired pneumonia (CAP) (48%), 115 were HAP (24%) and 131 were VAP (28%). Aspiration pneumonia was most commonly suspected in HAP. Table 2 summarizes patient comorbidities and their severity. Antibiotic use and organ failures are summarized in Table 3 .
Risk Factors for Pneumonia
The risk factors for each type of pneumonia are summarized in Tables 4 to 6 
Patient Outcomes
Pneumonia and NP patients had similar mortality rates (32% compared to 29%, P=0.11. Table 1 ). For CAP patients, pneumonia was the most likely cause of death. In no VAP patient did the clinician consider the cause of death solely due to pneumonia (P<0.001, Table 2 ). Clinical triage of CAP patients to the ward seemed appropriate as the mean ward SOFA scores the day before were significantly lower than those at the time of ICU admission (3.9 compared to 6.3, P<0.001). Ward SOFA scores were not predictive of ICU mortality (P=0.21).
Tables 7 to 10 detail the regression models for ICU mortality. Bronchoscopy was performed in 26% of all pneumonias and although was associated with an increase in ICU mortality (38% compared to 24%, P<0.01) it did not remain an independent predictor when illness severity, comorbid diseases and age were considered. The principal independent mortality risks in all pneumonia patients were immunodeficiency (OR 3.15, CI 95% 1.50-6.62, P=0.003), illness severity assessed as "life-threatening" by the attending consultant (OR 2.71, CI 95% 1. 26-5.83 The predictive ability of the illness severity assessments used in the study varied with pneumonia type. Although the clinician's subjective assessment of a "life-threatening" pneumonia (OR 2.71, CI 95% 1.26-5.83, P=0.01), SOFA score (OR 1.13, CI 95% 1.05-1.23, P<0.01) and SAPS II score (OR 1.02, CI 95% 1.01-1.04, P<0.01) were small independent predictors of mortality when pneumonia patients were considered together, only SOFA scores remained independent mortality predictors for CAP (OR 1.19, CI 95% 1.08-1.30, P<0.001) and VAP (OR 1.44, CI 95% 1.20-1.75, P=0.001) and the SAPS II score for HAP (OR 1.05, CI 95% 1.02-1.08, P<0.01).
The majority of changes in antibiotics were for rationalization (87%). Changes in antibiotics initially prescribed were more common in VAP compared with CAP or HAP (OR 2.31, CI 95% 1.50-3.58, P<0.001). The rate of inappropriate antibiotic prescription was low and similar for all pneumonia types (11-13%, P=0.88). The low prevalence of inappropriate antibiotic prescription weakened its mortality association. Changing antibiotics did not influence mortality for HAP and VAP but appropriate antibiotic change within three days of ICU admission did improve outcome for CAP (OR 0.46, CI 95% 0.24-0.86, P=0.01). No antibiotic group was associated with ICU mortality controlling for pneumonia type and severity. The mortality rates were similar for all pneumonia types regardless of whether one (31%) or more (33%) antibiotics were used in the first 24 hours (P=0. 35 received non-invasive ventilation (NIV) alone (22%) or combined with invasive ventilation (25%) with a trend to an improved outcome when compared to patients who received only invasive ventilation (40%, P=0.07). HAP patients also had similar mortalities whether receiving NIV alone (13%) or combined with invasive ventilation (11%) but both were significantly better than patients receiving only invasive ventilation (47%, P=0.03). Combining CAP and HAP patients for sufficient numbers for analysis, model and were not independent predictors of CAP and HAP mortality.
DISCUSSION
Pneumonia in the ICU represented 42% of all admissions and despite antibiotics and organ system support, the mortality was 32%. Such a large proportion of ICU patients with substantial mortality makes understanding of disease risks and mortality predictors important to plan mitigation strategies. The admission type most commonly associated with HAP and VAP appears sensitive to casemix and the proportion of emergency admissions. VAP was more common in trauma patients and HAP in medical patients. Pneumonia developed in 16% of our trauma patients. The prevalence of VAP in trauma patients is between 6% and 33% using similar diagnostic methodologies to our study 13, 14 , the range perhaps reflecting injury severity 14 . The emergency nature of the admission is important with medical and unscheduled surgical patients having equal VAP frequencies.
For CAP, chronic obstructive airways disease, chronic respiratory failure, immunosuppression, chronic heart failure, diabetes mellitus, the total number of pre-existing illnesses and drug abuse are risks for both ICU and general ward patients 15, 16, 17 . The absence of pre-existing illness was more common in our ventilated CAP patients (37%) compared to that reported for CAP patients admitted to wards (14.4%) 16 . This may reflect a selection bias of admitting younger patients with fewer pre-existing illnesses to the ICU. Despite this, CAP patients did have a greater number of rapidly or ultimately fatal illnesses than other pneumonia types. In CAP patients, our rates of alcoholism, drug abuse, immunosuppression and cancer were lower or similar to previous studies 16, 17 .
Our study, like others, found that HAP prevalence increased with age, the number of pre-existing illnesses, the duration of ward admission and male gender 18, 19, 20 cancer were the principal risks for HAP. In contrast to other studies, recent thoracic or emergency surgery and alcoholism were not predictive in our study 19, 20 .
In the VAP patients, principal risk factors included alcoholism, trauma, COAD and chronic heart failure 21, 22 . Although individual comorbidities were associated with the development of VAP, unlike other studies, our study did not demonstrate that the total number of comorbidities increased VAP risk 22, 23 . Despite COAD being a risk factor for VAP in the literature, we found its prevalence lower compared with patients presenting with CAP or HAP 24 . COAD may be more a marker of pneumonia risk than VAP in particular. All pneumonia types had similar mortality. Preexisting illnesses and their severity, although associated with pneumonia mortality 5, 25 , differed with pneumonia type. For CAP and HAP, a pre-existing history of non-metastatic cancer, immunosuppression, and chronic heart failure predicted mortality while cirrhosis and alcoholism were associated with increased VAP mortality. The association with nonmetastatic cancer has not previously been reported.
Objective scoring pneumonia severity in the ICU is predictive of mortality 21, 26 . SAPS II scoring on ICU admission was not predictive of the outcome for VAP. This probably reflects its calculation remote from the illness severity at the time of VAP onset. Individual components of the SOFA score varied in their mortality prediction for the different types of pneumonia, perhaps reflecting VAP generally represented milder illness compared to CAP or HAP. Clinical signs of consolidation independently predicted CAP mortality. This is a useful and previously unreported finding with its relatively high odds ratio (OR 2.43, CI 95% 1.09-5.44) only exceeded by immunosuppression. Clinical signs of consolidation generally represent lobar pneumonia and more likely to be found in CAP. Despite bacteraemia generally being associated with increased mortality 27 , we did not find this association in CAP.
The use of a single, appropriate antibiotic resulted in similar outcomes to multiple antibiotics as previously described 28, 29 . In VAP patients, the need to change inappropriate antibiotics after the onset of pneumonia does not change mortality 30, 31 and worsens mortality for CAP 32 . Changes from initial antibiotic therapy for nosocomial pneumonia may be up to 43%, mostly for simplification 33 . In our study, most changes in antibiotic therapy were for rationalizing rather than inappropriate antibiotic therapy. At least for CAP, rationalizing of antibiotic therapy when sensitivities are known improves patient outcome.
The predictors for mortality in HAP requiring ICU admission have been poorly defined with many studies combining HAP with other pneumonia types 34, 35 . Our study found similar mortality risks in the ICU group to those found in general ward patients 20, 36 . Unlike previous studies, we did not find that renal dysfunction, prior use of antibiotics or isolation of "high risk" microorganisms increased mortality risk for HAP 20, 36 .
The principal independent risk factors for mortality for VAP patients in our study were alcoholism and the presence of "high-risk organisms". VAP due to high-risk organisms has been associated with poorer outcomes 37, 38 . Unlike CAP, bacteraemia was a risk for VAP mortality and perhaps more likely to be found as blood cultures are more likely to be taken before a change of antibiotic therapy 39 . The effect of bacteraemia did not remain a predictor in multivariate modeling, reflecting its effects being represented by other measures of illness severity.
Combining all pneumonia patients, our study noted ward admission greater than two days before transfer to the ICU was an independent predictor of mortality. Previous studies have found a trend to increased mortality in CAP patients where there was a delay in ICU admission 40 . Our findings are consistent with this. Triage to ward care seemed appropriate for most of our patients when pre-ICU SOFA scores were examined. The ability to improve outcome in pneumonia patients by earlier ICU transfer has not been proven 41 . Although admission to the ward before ICU is a predictor of both length of ICU stay and ICU mortality, it is not possible to comment further on whether significant improvements could have been made in the pre-ICU care. Certainly, admission to the ward for CAP before ICU admission is a marker of poorer compliance with national guidelines. Poorer outcomes are reported when compliance with national guidelines is low but this was not confirmed in our study as antibiotic spectrum was generally appropriate 42 . Although it is possible that the severity of the pneumonia was not appreciated, there is an argument that pneumonia of sufficient severity to require an inpatient admission should be treated in the same way as severe pneumonia 43 .
The use of NIV as part of acute pneumonia management is increasing despite the lack of persuasive evidence of its effectiveness 44 . Our CAP and HAP patients receiving NIV had an improved mortality 45 and similar needs for invasive ventilation to published reports 46 . Patients needing both NIV and invasive ventilation had greater illness severities of their cardiovascular and respiratory systems.
Study Strengths and Limitations
Generalization of the findings to a broad intensive care patient population is supported by the range of intensive care units included in the study. Using a ventilated comparison group derived from within the ICU casemix allowed investigation of risks particular to the ICU population controlled for the effects of mechanical ventilation and was consistent with previous ICU studies. The principal limitation was the reliance on a clinical diagnosis of pneumonia in the absence of a specific diagnostic test. This is discussed in more detail in an allied report 4 . Inclusion of patients without pneumonia is possible, challenging the validity of the study but reflects the clinical reality of pneumonia diagnosis. All included patients did however meet the criteria of published definitions [7] [8] [9] . In addition, the regression models were robust with several previously unreported associations described.
SUMMARY AND CONCLUSIONS
Chronic obstructive airways disease remains an important risk for pneumonia presenting to the ICU. Alcoholism and immunosuppression are significant predictors of pneumonia mortality, making these groups potential early referrals to critical care services. Community-acquired pneumonia patients appear to be appropriately triaged to the ward prior to ICU but the need for transfer clearly is a marker of ICU mortality. Clinical signs of consolidation identify patients with high mortality and perhaps these patients might be deserving of early ICU admission. A single antibiotic of adequate spectrum is appropriate for the management of pneumonia where circumstances allow. In community-acquired pneumonia, early rationalising of antibiotics is associated with an improved outcome. Non-invasive ventilation is commonly used in the management of acute pneumonia with the adjunctive need for invasive ventilation predicted by higher illness severities of the cardiovascular and respiratory systems. Non-invasive ventilation is associated with an improved outcome.
